Unveiling 4 Analyst Insights On Ingevity
Portfolio Pulse from Benzinga Insights
Ingevity (NYSE:NGVT) has received mixed ratings from analysts over the past quarter, with a recent average price target of $51.5, down from $53.0. Analysts from Oppenheimer, Wells Fargo, BMO Capital, and Loop Capital have adjusted their ratings and price targets, reflecting varied sentiments. Ingevity faces financial challenges, including a decline in revenue growth, low net margin, and high debt-to-equity ratio.
August 01, 2024 | 5:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ingevity has received mixed ratings from analysts, with a recent average price target of $51.5, down from $53.0. Analysts from Oppenheimer, Wells Fargo, BMO Capital, and Loop Capital have adjusted their ratings and price targets, reflecting varied sentiments. The company faces financial challenges, including a decline in revenue growth, low net margin, and high debt-to-equity ratio.
The mixed analyst ratings and lowered price targets indicate a cautious outlook on Ingevity's stock. The company's financial challenges, such as declining revenue growth, low net margin, and high debt-to-equity ratio, further contribute to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100